Annual Report 10-11 - Elder Pharmaceuticals Ltd.
Annual Report 10-11 - Elder Pharmaceuticals Ltd.
Annual Report 10-11 - Elder Pharmaceuticals Ltd.
- No tags were found...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
28 th <strong>Annual</strong> <strong>Report</strong>20<strong>10</strong> - <strong>11</strong>Company OverviewBoard and Management <strong>Report</strong>sFinancial StatementsIN 20<strong>10</strong>-<strong>11</strong>,WE ADOPTED THE FOLLOWING INITIATIVES:OTHER IMPORTANT INITIATIVES COMPRISE:Formation of Elvista - Rural Market divisionpenetration and to enhancerecognition, the Companyto display products in theAntibioticsNeutraceuticalsGastrointestinal CarePain ManagementCough & ColdAnti-malarialFormation of Adventus - Mass Market initiativewith a focus on GPs (General Practitioners)Adventus is a multi-specialty division present in the anti-infectives,Efforts are concentratedon launching economicalproducts in mass-marketsEfforts are concentrated on launching economical products in these23
Change language